- Home
- BWMN vs KOD Comparison
BWMN vs KOD Comparison
Compare BWMN & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMN
- KOD
- Stock Information
- Founded
- BWMN 1995
- KOD 2009
- Country
- BWMN United States
- KOD United States
- Employees
- BWMN N/A
- KOD N/A
- Industry
- BWMN Military/Government/Technical
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BWMN Consumer Discretionary
- KOD Health Care
- Exchange
- BWMN Nasdaq
- KOD Nasdaq
- Market Cap
- BWMN 737.1M
- KOD 795.5M
- IPO Year
- BWMN 2021
- KOD 2018
- Fundamental
- Price
- BWMN $42.46
- KOD $11.72
- Analyst Decision
- BWMN Strong Buy
- KOD Buy
- Analyst Count
- BWMN 3
- KOD 6
- Target Price
- BWMN $38.17
- KOD $14.33
- AVG Volume (30 Days)
- BWMN 109.4K
- KOD 1.1M
- Earning Date
- BWMN 11-05-2025
- KOD 11-13-2025
- Dividend Yield
- BWMN N/A
- KOD N/A
- EPS Growth
- BWMN N/A
- KOD N/A
- EPS
- BWMN 0.61
- KOD N/A
- Revenue
- BWMN $462,176,000.00
- KOD N/A
- Revenue This Year
- BWMN $18.16
- KOD N/A
- Revenue Next Year
- BWMN $7.88
- KOD N/A
- P/E Ratio
- BWMN $69.08
- KOD N/A
- Revenue Growth
- BWMN 19.48
- KOD N/A
- 52 Week Low
- BWMN $17.90
- KOD $1.92
- 52 Week High
- BWMN $44.25
- KOD $19.39
- Technical
- Relative Strength Index (RSI)
- BWMN 54.06
- KOD 45.51
- Support Level
- BWMN $41.63
- KOD $11.42
- Resistance Level
- BWMN $43.43
- KOD $15.01
- Average True Range (ATR)
- BWMN 1.19
- KOD 1.75
- MACD
- BWMN -0.14
- KOD -0.49
- Stochastic Oscillator
- BWMN 57.71
- KOD 3.76
About BWMN Bowman Consulting Group Ltd.
Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.